8.3
View the full transcript and gain access to JoVE Core videos
Q1: What does pharmacokinetics describe for local anesthetics?
Pharmacokinetics describes how local anesthetics are absorbed, distributed, metabolized, and eliminated from the body. These processes directly affect the potency and duration of action of the anesthetic. Understanding pharmacokinetics helps clinicians predict how quickly an anesthetic will work and how long its effects will last.
Q2: Why are vasoconstrictors added to local anesthetics?
Vasoconstrictors like epinephrine reduce local blood flow, preventing local anesthetics from escaping into the systemic circulation. This localizes the anesthetic at the target site, enhances neuronal uptake, and prolongs the blockade. Vasoconstrictors also reduce systemic toxicity, lower total anesthetic requirements, and extend anesthesia duration for lengthy surgical procedures.
Q3: How does the distribution of local anesthetics depend on tissue type?
Local anesthetic distribution varies by target tissue properties. For example, when an anesthetic is injected into the subarachnoid space with the same density as cerebrospinal fluid, it remains static, allowing localized anesthesia as long as the patient stays upright. Tissue density and composition determine whether the anesthetic spreads or remains confined to the injection site.
Q4: What is the difference between ester and amide local anesthetic metabolism?
Ester-linked local anesthetics like procaine are metabolized by serum cholinesterases, while most amide-linked anesthetics are metabolized in the liver by cytochrome P450 enzymes. Both pathways produce water-soluble metabolites that are eliminated by the kidneys, but the different enzyme systems affect metabolism rates and drug interactions.
Q5: What unwanted effects can vasoconstrictors cause in local anesthesia?
Although vasoconstrictors enhance anesthetic efficacy, they can increase the probability of tissue necrosis and edema at the injection site. They may also reduce local oxygen supply, resulting in delayed wound healing. In susceptible individuals, vasoconstrictors can increase blood pressure and cause arrhythmia, requiring careful patient selection and monitoring.
Q6: How does systemic absorption of local anesthetics affect their clinical use?
When local anesthetics are administered in vascular tissues, they are rapidly absorbed and enter the systemic circulation, reducing their localized effects and increasing toxicity risk. This is why vasoconstrictors are often added to limit anesthetic escape into systemic circulation, ensuring the drug remains concentrated at the target area for effective local anesthesia.
Q7: How do local anesthetics work in different clinical applications?
Local anesthetics are used in various clinical settings including local anesthetics clinical application as surface infiltration and conduction block anesthesia, epidural anesthesia, and spinal anesthesia. Each application route affects how the anesthetic is distributed and how long it remains effective, depending on tissue type, vascularity, and the presence of vasoconstrictors.